MARKET

AVNS

AVNS

Avanos Medical
NYSE

Real-time Quotes | Nasdaq Last Sale

42.82
+0.20
+0.47%
Closed 16:31 05/06 EDT
OPEN
42.50
PREV CLOSE
42.62
HIGH
42.90
LOW
41.46
VOLUME
361.19K
TURNOVER
--
52 WEEK HIGH
53.61
52 WEEK LOW
24.71
MARKET CAP
2.06B
P/E (TTM)
-74.8732
1D
5D
1M
3M
1Y
5Y
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6)
Benzinga · 1h ago
Avanos Medical EPS beats by $0.05, beats on revenue
Avanos Medical (AVNS): Q1 Non-GAAP EPS of $0.23 beats by $0.05; GAAP EPS of -$0.16 misses by $0.23.Revenue of $181M (+0.3% Y/Y) beats by $5.32M.The Company expects 2021 net sales
Seekingalpha · 1h ago
Avanos Medical Q1 EPS $0.23 Beats $0.18 Estimate, Sales $181.00M Beat $175.44M Estimate
Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.18 by 27.78 percent. This is a 43.75 percent increase over earnings of $0.16 per share from the
Benzinga · 1h ago
BRIEF-Avanos Medical, Inc. Announces First Quarter 2021 Results
reuters.com · 1h ago
Earnings Scheduled For May 7, 2021
  Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter.
Benzinga · 4h ago
Avanos Medical Q1 Adjusted EPS, Revenue Increase
MT Newswires · 5h ago
-- Earnings Flash (AVNS) AVANOS MEDICAL Posts Q1 Revenue $180.7M, vs. Street Est of $175.7M
MT Newswires · 5h ago
-- Earnings Flash (AVNS) AVANOS MEDICAL Reports Q1 EPS $0.23, vs. Street Est of $0.18
MT Newswires · 5h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AVNS. Analyze the recent business situations of Avanos Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AVNS stock price target is 52.00 with a high estimate of 60.00 and a low estimate of 45.00.
EPS
Institutional Holdings
Institutions: 439
Institutional Holdings: 48.79M
% Owned: 101.53%
Shares Outstanding: 48.06M
TypeInstitutionsShares
Increased
46
1.16M
New
47
491.84K
Decreased
95
1.84M
Sold Out
35
633.64K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.50%
Healthcare Equipment & Supplies
-0.26%
Key Executives
Non-Executive Chairman/Independent Director
Gary Blackford
Chief Executive Officer/Director
Joseph Woody
Chief Financial Officer/Senior Vice President
Michael Greiner
Senior Vice President/Chief Compliance Officer
Michelle Scharfenberg
Senior Vice President/General Manager
Bill Haydon
Senior Vice President/General Counsel/Secretary
S. Ross Mansbach
Senior Vice President/General Manager
William Haydon
Senior Vice President
David Ball
Senior Vice President
Arjun Sarker
Independent Director
John Byrnes
Independent Director
Heidi Kunz
Independent Director
Patrick O'leary
Independent Director
Patrick O'Leary
Independent Director
Maria Sainz
Independent Director
Julie Shimer
No Data
About AVNS
Avanos Medical, Inc., formerly Halyard Health, Inc., is a medical technology company. The Company provides a portfolio of product offerings focused on surgical and interventional pain management, respiratory and digestive health. Its products include post-operative pain management solutions, minimally invasive interventional or chronic pain therapies, closed airway suction systems and enteral feeding tubes. The company’s products are sold under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, QUIKBLOC, HOMEPUMP, CORTRAK and other brand names.

Webull offers kinds of Avanos Medical Inc stock information, including NYSE:AVNS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVNS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVNS stock methods without spending real money on the virtual paper trading platform.